Navigation Links
Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
Date:6/14/2013

SOUTH EASTON, Mass., June 14, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that it has closed the third and final tranche of its Series J Private Placement of Convertible Preferred Stock and Warrants (the "Series J Private Placement").  Combined with two earlier tranche closings ($1,702,800 on February 6 and $156,900 on March 28, 2013), the Company has now closed a total of $2,034,800 in its Series J Private Placement, slightly over its goal of $2.0 million. The investors in the Series J Private Placement included all members of the Company's Board of Directors, plus new and existing accredited investors in PBI.

The transaction consisted of the sale of 5,087 units of Series J Preferred Stock and Warrants to purchase the Company's Common Stock (the "Common Stock"). The price per unit was $400.00. Each unit consisted of one (1) share of Series J Preferred Stock (convertible into 1,000 shares of Common Stock at a Common Stock equivalent price of $0.40 per share) and a Warrant to purchase 1,000 shares of restricted Common Stock.  The Warrants are exercisable for a period of three (3) years from the applicable closing date, at an exercise price equal to $0.40 per share. Of the $2,034,800 amount, $921,100 was in cash and $1,113,700 was from the conversion of debt.

The Company also announced the closing of a $500,000, one-year, convertible debenture (the "Note") with an institutional investor (the "Investor") on Friday, June 7, 2013.  Interest on the Note is 10%.  Under the terms of the Note, the Company received $250,000 at the initial closing, and is to receive $100,000 on or before July 7, 2013 and $150,000 on or before August 6, 2013 in a second and third closing.  The Investor has the right to convert the Note into Common Stock of the Company at any time six months after each Closing Date. The Company has the right to pre-pay the Note at
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
2. High pressure gold nanocrystal structure revealed
3. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
4. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
5. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
6. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
7. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
8. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
10. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
11. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... A new report by  visiongain  forecasts the ... in 2019. That revenue forecast and others appear in  ... ,  published in March 2015. ... and qualitative analyses of the antithrombotic drugs market. Visiongain ... London, UK . It produces analyses to ...
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 ... that Roger Jeffs , Ph.D., President and Co-Chief Executive ... on the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on ... can be accessed via a live webcast on the United ...
(Date:4/30/2015)... 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) reported total ... were $4.4 million, compared to $8.0 million during the same ... quarter was $8.9 million, or $0.23 per basic and diluted ... same period in 2014, of $8.7 million, or $0.27 per ... cash, cash equivalents and investments totaled $117.5 million. , ...
(Date:4/30/2015)... YORK , April 30, 2015 The following ... Board of Directors of China Cord Blood Corp (NYSE: ... the special committee of the independent directors of China Cord ... low privatization offer of $6.40 per share from Golden Meditech ... at $6.40 per share would greatly benefit Golden Med and ...
Breaking Biology Technology:Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5
... Spinal Cells in Future, ROCKVILLE, Md., Feb. 20 ... announces that Korean conglomerate, CJ,CheilJedang Corporation (KSE: CJ CheilJedang) ... to Neuralstem,s stem cell-products and,technology after the company completes ... CJ has purchased $2.5 million worth of Neuralstem,stock at ...
... Inc. (Amex: IMA ), a global leader in ... the quarter,ended December 31, 2007., In the fourth ... million compared to net revenue of $157.0 million in ... due to increased,product sales in our Professional Diagnostics segment ...
... Inc.,(Nasdaq: OSTE ), a leader in the emerging ... total revenue for the year,ending December 31, 2007 increased ... year ended December 31, 2006. Revenue from "core" product,lines, ... year,2007, an increase of 15% over core product revenue ...
Cached Biology Technology:Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation 2Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation 3Inverness Medical Innovations Announces Fourth Quarter 2007 Results 2Inverness Medical Innovations Announces Fourth Quarter 2007 Results 3Inverness Medical Innovations Announces Fourth Quarter 2007 Results 4Inverness Medical Innovations Announces Fourth Quarter 2007 Results 5Inverness Medical Innovations Announces Fourth Quarter 2007 Results 6Inverness Medical Innovations Announces Fourth Quarter 2007 Results 7Inverness Medical Innovations Announces Fourth Quarter 2007 Results 8Inverness Medical Innovations Announces Fourth Quarter 2007 Results 9Inverness Medical Innovations Announces Fourth Quarter 2007 Results 10Inverness Medical Innovations Announces Fourth Quarter 2007 Results 11Inverness Medical Innovations Announces Fourth Quarter 2007 Results 12Inverness Medical Innovations Announces Fourth Quarter 2007 Results 13Inverness Medical Innovations Announces Fourth Quarter 2007 Results 14Inverness Medical Innovations Announces Fourth Quarter 2007 Results 15Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 2Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 3Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 4Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 5Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 6
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/27/2015)... Fla. , Apr. 27, 2015 Profile ... access control and security systems is pleased to announce ... company as a consultant and member of its scientific ... is widely known as a thought leader in technology-enhanced ... Learning Technology Group, and has published studies and books ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... quest for healthier, younger looking skin, scientists from ... have made an important discovery toward manipulating skin ... range from helping doctors develop more natural looking ... new products for achieving the perfect sunless tan. ...
... mediated phosphorylation is generally recognised as the major ... cells including proliferation, gene expression, motility, vesicular transport ... plays a major role in many diseases such ... elucidation of many kinase cascades has proved pivotal ...
... have struggled to chase down speeding vehicles as the movie ... fearsome carnivore was certainly no slouch, research out today suggests. ... to calculate the running speeds of five meat-eating dinosaurs that ... Tyrannosaurus. The study believed to be the most ...
Cached Biology News:Scientists discover important beauty secret for balanced skin color and tone 2All eukaryotic kinases share 1 common set of substrates 2T. rex quicker than Becks, say scientists 2
... Series of systems provide fast and ... discovery, genomics, proteomics and drug development ... three base configurations; Mini Workstation Series, ... All Staccato Application Series systems ...
... on over 20 years of experience in ... Life Sciences, the Freedom EVO platform delivers ... according to future needs. Together with the ... is equipped to successfully operate genomics, proteomics, ...
... novel disposable spin filtration device especially designed ... in plasmid purification procedures. , ,The ... filtration device especially designed to aid the ... procedures. The neutralized lysate is centrifuged at ...
Comp Dim: chamber L W D 45 45 0.8 mm chamber maximum volume 1500 μL...
Biology Products: